Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06219577 · ClinicalTrials.gov registry record · Phase 4
Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance
A Phase 4 study, sponsored by Scripps Poway Eyecare and Optometry.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT06219577: Completed Phase 4 study, sponsored by Scripps Poway Eyecare and Optometry.
NCT06219577 is a Phase 4 study that has completed, run by Scripps Poway Eyecare and Optometry. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06219577, a Phase 4 study, has completed, sponsored by Scripps Poway Eyecare and Optometry.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
Single site, prospective, double-masked, randomized-controlled, two-arm study of the dry eye symptoms as well as corneal and conjunctival staining in subjects using 2 different eyedrops. Subjects will be assessed at a screening visit, and 2 follow-up visits. Clinical evaluations will include patient questionnaire, tear-breakup time, and slit lamp exam.
Primary Outcome
The Symptom Assessment iN Dry Eye (SANDE) questionnaire. Subjects are asked to place an 'X' on the line to indicate both the frequency and severity of their dry eye symptoms. Each question is scored from 0 to 100. The scores for frequency and severity are used to calculate a total score, where Total Score = square.root\[Q1 \* Q2\]. Higher total score on the questionnaire indicates more frequent or severe dry eye symptoms.
Interventions
- DRUG Systane Complete Multi-Dose PF
- DRUG Walgreen's Lubricant Balance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2024-04-22 |
| Phase | Phase 4 |
What the finished NCT06219577 record still lists
NCT06219577 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Systane Complete Multi-Dose PF is the first listed.
NCT06219577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06219577 about?
NCT06219577 is a clinical study titled "Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance". Single site, prospective, double-masked, randomized-controlled, two-arm study of the dry eye symptoms as well as corneal and conjunctival staining in subjects using 2 different eyedrops. Subjects will be assessed at a screening visit, and 2 follow-up visits. Clinical evaluations will include patient...
What is the current status of trial NCT06219577?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2024-01-18. Estimated completion is 2024-04-22.
What interventions are being tested in trial NCT06219577?
The interventions under investigation include: Systane Complete Multi-Dose PF (DRUG), Walgreen's Lubricant Balance (DRUG).
Who is sponsoring clinical trial NCT06219577?
This trial is sponsored by Scripps Poway Eyecare and Optometry, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06219577's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI